Arkolith/Insider Trading/AURX/Form 4

Pittman Scott M.

Director, 10% OwnerNuo Therapeutics, Inc. (AURX) · full profile →Form 4 · filed Nov 19, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2024Option exercise(M)122K$0.40$49K5.3M
Nov 15, 2024Option exercise(M)33K$0.50$17K5.4M
Nov 15, 2024Option exercise(M)63K$0.40$25K5.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2022Option exercise(M)33K—$00
Dec 31, 2018Option exercise(M)63K—$00
Aug 9, 2018Option exercise(M)122K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-035771) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Nuo Therapeutics, Inc.

Build

Ask your agent about AURX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-24-035771"
Ask your agent
Use Arkolith to summarize insider buying and selling at Nuo Therapeutics, Inc.
over the last 90 days and cite the filings.